Complement Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Complement Therapeutics's estimated annual revenue is currently $2.5M per year.
- Complement Therapeutics's estimated revenue per employee is $77,500
- Complement Therapeutics's total funding is $85M.
Employee Data
- Complement Therapeutics has 32 Employees.
- Complement Therapeutics grew their employee count by 100% last year.
Complement Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Chief Scientific Officer | Reveal Email/Phone |
4 | Associate Director, Programme Management | Reveal Email/Phone |
Complement Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.2M | 16 | 23% | N/A | N/A |
#2 | $11.8M | 76 | 21% | N/A | N/A |
#3 | $1.8M | 23 | 35% | N/A | N/A |
#4 | $2.2M | 29 | 61% | N/A | N/A |
#5 | $1.8M | 23 | 35% | N/A | N/A |
#6 | $0.9M | 12 | 9% | N/A | N/A |
#7 | $0.1M | 1 | 0% | N/A | N/A |
#8 | $18.3M | 118 | -3% | N/A | N/A |
#9 | $0.5M | 6 | 20% | N/A | N/A |
#10 | $4.8M | 62 | 41% | N/A | N/A |
What Is Complement Therapeutics?
Complement Therapeutics (CTx) is an early-stage biotechnology company focused on the research and development of novel therapeutics for complement-mediated diseases. The Company is a spinout from the University of Manchester and is based on the pioneering research of its founders into novel targets within the complement cascade. Our lead investigational product (CTx001) is being evaluated as a potential gene therapy for dry age-related macular degeneration/geographic atrophy, a leading cause of blindness. Additional programmes will evaluate potential therapeutic opportunities in other complement-mediated conditions. The Company is also developing a unique quantification methodology, the Complement Precision Medicine (CPM) platform, to enable quantification of over 30 complement cascade proteins enabling more precise diagnosis and monitoring of disease.
keywords:N/A
$85M
Total Funding
32
Number of Employees
$2.5M
Revenue (est)
100%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in London
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.6M | 32 | -11% | N/A |
#2 | $6.2M | 32 | 0% | N/A |
#3 | $3.3M | 32 | 0% | N/A |
#4 | $4.2M | 32 | 7% | N/A |
#5 | $6.4M | 32 | 3% | N/A |